TrialBMC infectious diseases2011

Core mutations, IL28B polymorphisms and response to peginterferon/ribavirin treatment in Swedish patients with hepatitis C virus genotype 1 infection.

Erik Alestig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.